ATP binding cassette subfamily G member 2 (Junior blood group) ; Homo sapiens

14 Article(s)
Pub. Year
#Total Relationships
1 34780725 Dabrafenib inhibits ABCG2 and cytochrome P450 isoenzymes; potential implications for combination anticancer therapy. 2022 Jan 1 1
2 29327946 Posttranscriptional Regulation of Human Antigen R by miR-133b Enhances Docetaxel Cytotoxicity Through the Inhibition of ATP-Binding Cassette Subfamily G Member 2 in Prostate Cancer Cells. 2018 Mar 3
3 29678549 Reversal of drug resistance by planetary ball milled (PBM) nanoparticle loaded with resveratrol and docetaxel in prostate cancer. 2018 Jul 28 2
4 30555232 Activation of polymeric nanoparticle intracellular targeting overcomes chemodrug resistance in human primary patient breast cancer cells. 2018 2
5 30555629 The estrogen receptor variants β2 and β5 induce stem cell characteristics and chemotherapy resistance in prostate cancer through activation of hypoxic signaling. 2018 Nov 20 1
6 28300564 Contrasting roles of the ABCG2 Q141K variant in prostate cancer. 2017 May 1 1
7 23053273 Changing the expression vector of multidrug resistance genes is related to neoadjuvant chemotherapy response. 2013 Jan 1
8 23758476 Pharmacogenomics variation in drug metabolizing enzymes and transporters in relation to docetaxel toxicity in Lebanese breast cancer patients: paving the way for OMICs in low and middle income countries. 2013 Jul 1
9 21262849 Ixabepilone, a novel microtubule-targeting agent for breast cancer, is a substrate for P-glycoprotein (P-gp/MDR1/ABCB1) but not breast cancer resistance protein (BCRP/ABCG2). 2011 May 1
10 21468756 The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patients. 2011 Jun 2
11 20829196 I-387, a novel antimitotic indole, displays a potent in vitro and in vivo antitumor activity with less neurotoxicity. 2010 Nov 1
12 18056989 The 44-kDa Pim-1 kinase phosphorylates BCRP/ABCG2 and thereby promotes its multimerization and drug-resistant activity in human prostate cancer cells. 2008 Feb 8 1
13 17062685 Hoosier Oncology Group randomized phase II study of docetaxel, vinorelbine, and estramustine in combination in hormone-refractory prostate cancer with pharmacogenetic survival analysis. 2006 Oct 15 1
14 14617793 Taxane-based reversal agents modulate drug resistance mediated by P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein. 2003 Nov 1